Cause and effect links between GSH metabolism and diseases such as cancer, neurodegenerative diseases, cystic fibrosis (CF), HIV, and aging have been shown
The released drug molecules can then exert their therapeutic effects, such as inducing apoptosis in cancer cells
The molecule was first identified and studied by the Sikiric research group in Croatia starting in the early 1990s, and the bulk of the preclinical evidence base comes from more than three decades of rat and rodent studies showing consistent tissue-repair, anti-inflammatory, and gastroprotective effects
Published research has documented GHK-Cus role in stimulating collagen and elastin synthesis, modulating gene expression across thousands of pathways, reducing markers of oxidative stress, and supporting the cellular mechanisms behind wound healing and tissue remodeling